Toward a COVID-19 vaccine strategy for patients with pemphigus on rituximab

Detalles Bibliográficos
Autores principales: Waldman, Reid A., Creed, Marina, Sharp, Kelley, Adalsteinsson, Jonas, Imitola, Jaime, Durso, Timothy, Lu, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier on behalf of the American Academy of Dermatology, Inc. 2021
Materias:
JAAD Online
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598732/
https://www.ncbi.nlm.nih.gov/pubmed/33130180
http://dx.doi.org/10.1016/j.jaad.2020.10.075
_version_ 1783602697280159744
author Waldman, Reid A.
Creed, Marina
Sharp, Kelley
Adalsteinsson, Jonas
Imitola, Jaime
Durso, Timothy
Lu, Jun
author_facet Waldman, Reid A.
Creed, Marina
Sharp, Kelley
Adalsteinsson, Jonas
Imitola, Jaime
Durso, Timothy
Lu, Jun
author_sort Waldman, Reid A.
collection PubMed
description
format Online
Article
Text
id pubmed-7598732
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Published by Elsevier on behalf of the American Academy of Dermatology, Inc.
record_format MEDLINE/PubMed
spelling pubmed-75987322020-11-02 Toward a COVID-19 vaccine strategy for patients with pemphigus on rituximab Waldman, Reid A. Creed, Marina Sharp, Kelley Adalsteinsson, Jonas Imitola, Jaime Durso, Timothy Lu, Jun J Am Acad Dermatol JAAD Online Published by Elsevier on behalf of the American Academy of Dermatology, Inc. 2021-04 2020-10-29 /pmc/articles/PMC7598732/ /pubmed/33130180 http://dx.doi.org/10.1016/j.jaad.2020.10.075 Text en © 2020 Published by Elsevier on behalf of the American Academy of Dermatology, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle JAAD Online
Waldman, Reid A.
Creed, Marina
Sharp, Kelley
Adalsteinsson, Jonas
Imitola, Jaime
Durso, Timothy
Lu, Jun
Toward a COVID-19 vaccine strategy for patients with pemphigus on rituximab
title Toward a COVID-19 vaccine strategy for patients with pemphigus on rituximab
title_full Toward a COVID-19 vaccine strategy for patients with pemphigus on rituximab
title_fullStr Toward a COVID-19 vaccine strategy for patients with pemphigus on rituximab
title_full_unstemmed Toward a COVID-19 vaccine strategy for patients with pemphigus on rituximab
title_short Toward a COVID-19 vaccine strategy for patients with pemphigus on rituximab
title_sort toward a covid-19 vaccine strategy for patients with pemphigus on rituximab
topic JAAD Online
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598732/
https://www.ncbi.nlm.nih.gov/pubmed/33130180
http://dx.doi.org/10.1016/j.jaad.2020.10.075
work_keys_str_mv AT waldmanreida towardacovid19vaccinestrategyforpatientswithpemphigusonrituximab
AT creedmarina towardacovid19vaccinestrategyforpatientswithpemphigusonrituximab
AT sharpkelley towardacovid19vaccinestrategyforpatientswithpemphigusonrituximab
AT adalsteinssonjonas towardacovid19vaccinestrategyforpatientswithpemphigusonrituximab
AT imitolajaime towardacovid19vaccinestrategyforpatientswithpemphigusonrituximab
AT dursotimothy towardacovid19vaccinestrategyforpatientswithpemphigusonrituximab
AT lujun towardacovid19vaccinestrategyforpatientswithpemphigusonrituximab

Ejemplares similares